Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA. [electronic resource]
Producer: 20020104Description: 309-12 p. digitalISSN:- 1525-4135
- Anti-HIV Agents -- therapeutic use
- Antiretroviral Therapy, Highly Active
- Drug Resistance, Viral
- Drug Therapy, Combination
- Endopeptidases -- genetics
- Genes, pol
- Genotype
- HIV Infections -- blood
- HIV Reverse Transcriptase -- genetics
- HIV-1 -- drug effects
- Humans
- Mutation
- Nevirapine -- therapeutic use
- Prospective Studies
- Protease Inhibitors -- therapeutic use
- RNA, Viral -- blood
- Reverse Transcriptase Inhibitors -- therapeutic use
- Time Factors
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.